|
S100A7 (S100 calcium binding protein A7) |
Majesta O'Bleness, James Sikela |
Genetics |
|
|
HAR1 (human accelerated region 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
CDK5RAP2 (CDK5 regulatory subunit-associated protein 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CHRFAM7A (CHRNA7 (cholinergic receptor, nicotinic, alpha 7) and FAM7A (family with sequence similarity 7A) fusion) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SLC6A8 (solute carrier family 6 (neurotransmitter transporter, creatine), member 8) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
HYDIN (Hydrocephalus inducing homolog) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC12 (sialic acid binding Ig-like lectin 12) |
Ajit Varki |
Genetics |
Absolute Difference |
|
TBC1D3 (TBC domain family, member 3) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
FSHR (Follicle-stimulating hormone receptor) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CHRM3 (Cholinergic receptor, muscarinic 3) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
DRD4 (dopamine receptor D4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
LEPR (Leptin receptor) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC13 (sialic acid binding Ig-like lectin 13) |
Ajit Varki |
Genetics |
Absolute Difference |
|
ARHGAP11B (Rho GTPase Activating Protein 11B) |
Majesta O'Bleness |
Genetics |
Absolute Difference |
|
TDG (Thymine-DNA glycosylase) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
GADD45G (Growth arrest and DNA-damage-inducible protein 45 gamma) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CKB (Creatine kinase brain) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
ELN (elastin) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
MBL1P (mannose-binding lectin (protein A) 1, pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC5 (sialic acid binding Ig-like lectin 5 ) |
Ajit Varki |
Genetics |
Likely Difference |
|
TDH (L-threonin dehydrogenase) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
PAK2 (p21 activated kinase 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CLLU1 (Chronic lymphocytic leukemia up-regulated 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
FOXP2 (forkhead box P2) |
Naruya Saitou |
Genetics |
Absolute Difference |
|
MOXD2P (monooxygenase, DBH-like 2, pseudogene ) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MRC1 (Mannose receptor, C type 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC6 (sialic acid binding Ig-like lectin 6) |
Ajit Varki |
Genetics |
Absolute Difference |
|
FZD8 (frizzled 8) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
THBS4 (Thrombospondin 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
AMY1A (amylase, alpha 1A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SLC2A1 (Solute carrier family 2 (facilitated glucose transporter) member 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
DDX11L (DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 like) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
NAIP (NLR family, apoptosis inhibitory protein ) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC9 (sialic acid binding Ig-like lectin 9) |
Ajit Varki |
Genetics |
Likely Difference |
|
DCHS1 (Dachsous Cadherin-Related 1) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
ZNF322 (Zinc finger protein 322) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
UOX (urate oxidase, pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
No Difference |
|
SLC2A4 (Solute carrier family 2 (facilitated glucose transporter) member 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
DNAH10OS (Dynein, axonemal heavy chain 10 opposite strand) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
KRT41P (keratin 41 pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
NCF1 (Neutrophil cytosolic factor 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
TAS2R38 (taste receptor, type 2, member 38) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
DUX4 (double homeobox 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
APOC1 (apolipoprotein C-I) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
DRD5 (Dopamine receptor D5) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
FGFR2 (fibroblast growth factor receptor 2) |
Matthew Boisvert, Majesta O'Bleness, James Sikela |
Genetics |
No Difference |
|
OCLN (Occludin) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
TTR (transthyretin) |
MOCA Author |
Genetics |
Likely Difference |
|
KIR3DL1 (killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
AQP7 (aquaporin 7) |
Laura Dumas, James Sikela |
Genetics |
Likely Difference |
|
DUSP22 (Dual specificity phosphatase 22) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MCPH1 (microcephalin 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
PDE4DIP (Phosphodiesterase 4D interacting protein) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
TH (tyrosine hydroxylase) |
Landon Klein |
Genetics |
Relative Difference |
|
CASC5 (Cancer Susceptibility Candidate 5 ) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
EDAR (ectodysplasin A receptor) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
E2F6 (E2F transcription factor 6) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MC1R (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) ) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
NBPF15 (neuroblastoma breakpoint family, member 15) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
PTPN20A (Protein tyrosine phosphatase, non-receptor type 20A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SPANXB (SPANX family, member B) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
FCGR1A (Fc fragment of IgG, high affinity Ia, receptor (CD64)) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MHC Class I |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
SERPINA13 (Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SPANXC (SPANX family, member C) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC14 (sialic acid binding Ig-like lectin 14) |
Ajit Varki |
Genetics |
Absolute Difference |
|
APOE (apolipoprotein E) |
Caleb Finch |
Genetics |
Relative Difference |
|
FRMPD2 (FERM and PDZ domain containing 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
Thyroid Hormone Metabolism |
MOCA Author |
Endocrinology |
Likely Difference |
|
DHEA/DHEAS Circulating Levels |
MOCA Author |
Endocrinology |
Relative Difference |
|
Androgen Metabolism in the Brain |
Camille Toarmino |
Endocrinology |
|
|
Arsenic Detoxification |
MOCA Author |
Pharmacology |
Likely Difference |
|
Mind-Altering Drug Use |
Landon Klein |
Pharmacology |
Likely Difference |
|
Self-Medication (Zoopharmacognosy) |
Majesta O'Bleness |
Pharmacology |
Relative Difference |
|
Polycystic Ovarian Disease |
Nissi Varki |
Pathology |
Absolute Difference |
|
Sarcoidosis |
Nissi Varki |
Pathology |
Speculative Difference |
|
Systemic Lupus Erythematosus |
Nissi Varki |
Pathology |
Speculative Difference |
|
Serum Lp(a) Level |
MOCA Author |
Pathology |
Relative Difference |
|
Serum Cholesterol Level |
Caleb Finch |
Pathology |
Likely Difference |
|
Serum Alkaline Phosphatase Level |
MOCA Author |
Pathology |
Relative Difference |
|
Serum Uric Acid Level |
MOCA Author |
Pathology |
Relative Difference |
|
Uterine Adenomyosis and Endometriosis |
Nissi Varki |
Pathology |
Relative Difference |
|
Alzheimer's Disease Pathology (Neurofibrillary Tangles) |
Caleb Finch |
Pathology |
Absolute Difference |
|
Blood Group Antigen Types and Prevalence |
Leela Davies |
Pathology |
Relative Difference |
|
Neoplasm Types and Prevalence |
Nissi Varki |
Pathology |
Relative Difference |
|
Erythrocyte Sedimentation Rate |
MOCA Author |
Pathology |
Relative Difference |
|
Atherosclerosis |
Nissi Varki |
Pathology |
Relative Difference |
|
Rheumatoid Arthritis |
MOCA Author |
Pathology |
Relative Difference |
|
Age-Associated Osteoporosis |
MOCA Author |
Pathology |
Speculative Difference |
|
Major Basic Protein in Placenta and Eosinophils |
MOCA Author |
Pathology |
Likely Difference |
|
Gout |
Nissi Varki |
Pathology |
Speculative Difference |
|
Absolute Leukocyte Count |
MOCA Author |
Pathology |
Absolute Difference |
|
Hemochromatosis |
Nissi Varki |
Pathology |
Speculative Difference |
|
Absolute Lymphocyte Count |
Robert Thomas |
Pathology |
Absolute Difference |
|
Inflammatory Bowel Disease |
Nissi Varki |
Pathology |
Speculative Difference |
|
Absolute Neutrophil Count |
MOCA Author |
Pathology |
Absolute Difference |
|
Colonic Polyps |
Nissi Varki |
Pathology |
Relative Difference |
|
Diverticulosis |
Nissi Varki |
Pathology |
Absolute Difference |
|
Benign Prostatic Hyperplasia |
Nissi Varki |
Pathology |
Likely Difference |
|
Deciduous Teeth Development/Morphology |
Robert Thomas |
Dental Biology and Disease |
Relative Difference |
